Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression

Background Metabolite levels reflect physiologic homeostasis and may serve as biomarkers of disease progression. Identifying metabolites associated with APOL1 risk alleles—genetic variants associated with CKD risk commonly present in persons of African descent—may reveal novel markers of CKD progres...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Soc Nephrol
Asıl Yazarlar: Tin, Adrienne, Nadkarni, Girish, Evans, Anne M., Winkler, Cheryl A., Bottinger, Erwin, Rebholz, Casey M., Sarnak, Mark J., Inker, Lesley A., Levey, Andrew S., Lipkowitz, Michael S., Appel, Lawrence J., Arking, Dan E., Coresh, Josef, Grams, Morgan E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2018
Konular:
Clinical Epidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050937/
https://ncbi.nlm.nih.gov/pubmed/29777021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2017101064
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller